NCT02127034View on ClinicalTrials.gov

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Healthy SubjectsPharmacokineticsDrug-Drug Interaction (DDI)

Interventions

DRUG

Mirabegron

oral

DRUG

Solifenacin

oral

DRUG

Digoxin

oral

Trial Locations (1)

14050

Parexel International GmbH, Berlin

All Listed Sponsors

lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT02127034 - Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects | Biotech Hunter | Biotech Hunter